The structure of the carbohydrate moiety of a natural phenolic glycoside can have a significant effect on the molecular interactions and physicochemical and pharmacokinetic properties of the entire compound, which may include anti‐inflammatory and anticancer activities. The enzyme 6‐ O ‐α‐rhamnosyl‐β‐glucosidase (EC 3.2.1.168) has the capacity to transfer the rutinosyl moiety (6‐ O ‐α‐ l ‐rhamnopyranosyl‐β‐ d ‐glucopyranose) from 7‐ O ‐rutinosylated flavonoids to hydroxylated organic compounds. This transglycosylation reaction was optimized using hydroquinone (HQ) and hesperidin as rutinose acceptor and donor, respectively. Since HQ undergoes oxidation in a neutral to alkaline aqueous environment, the transglycosylation process was carried out at pH values ≤6.0. The structure of 4‐hydroxyphenyl‐β‐rutinoside was confirmed by NMR, that is, a single glycosylated product with a free hydroxyl group was formed. The highest yield of 4‐hydroxyphenyl‐β‐rutinoside (38%, regarding hesperidin) was achieved in a 2‐h process at pH 5.0 and 30 °C, with 36 mM OH‐acceptor and 5% (v/v) cosolvent. Under the same conditions, the enzyme synthesized glycoconjugates of various phenolic compounds (phloroglucinol, resorcinol, pyrogallol, catechol), with yields between 12% and 28% and an apparent direct linear relationship between the yield and the p K a value of the aglycon. This work is a contribution to the development of convenient and sustainable processes for the glycosylation of small phenolic compounds.
No takes yet. Share an insight, caveat, or question.
Mazzaferro et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: